These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 16621425

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
    Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, Deraco M.
    Cancer; 2006 Mar 01; 106(5):1144-53. PubMed ID: 16456817
    [Abstract] [Full Text] [Related]

  • 4. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
    Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S.
    J Surg Oncol; 2003 Jul 01; 83(3):147-53. PubMed ID: 12827682
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
    Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras Ad AD, Kusamura S.
    Ann Surg Oncol; 2006 Feb 01; 13(2):229-37. PubMed ID: 16444562
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma.
    Deraco M, De Simone M, Rossi CR, Cavaliere F, Difilippo F, Scuderi S, Pilatti P, Kusamura S.
    J Exp Clin Cancer Res; 2003 Dec 01; 22(4 Suppl):41-5. PubMed ID: 16767905
    [Abstract] [Full Text] [Related]

  • 9. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
    Kusamura S, Deraco M, Baratti D, Inglese MG, Costanzo P, Favaro M, Manzi R, Gavazzi C.
    J Exp Clin Cancer Res; 2003 Dec 01; 22(4 Suppl):207-12. PubMed ID: 16767933
    [Abstract] [Full Text] [Related]

  • 10. Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D, Fountzilas G, Aravantinos G, Kalofonos HP, Efstathiou E, Salamalekis E, Farmakis D, Skarlos D, Briasoulis E, Economopoulos T, Dimopoulos MA.
    Gynecol Oncol; 2005 May 01; 97(2):436-41. PubMed ID: 15863142
    [Abstract] [Full Text] [Related]

  • 11. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Di Giorgio A, Naticchioni E, Biacchi D, Sibio S, Accarpio F, Rocco M, Tarquini S, Di Seri M, Ciardi A, Montruccoli D, Sammartino P.
    Cancer; 2008 Jul 15; 113(2):315-25. PubMed ID: 18473354
    [Abstract] [Full Text] [Related]

  • 12. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
    Massari R, Barone M, Basilico R, Carella C, Colasante A, De Tursi M, Filippone A, Guetti L, Mani A.
    Minerva Chir; 2014 Feb 15; 69(1):17-26. PubMed ID: 24675243
    [Abstract] [Full Text] [Related]

  • 13. Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study.
    Fagotti A, Paris I, Grimolizzi F, Fanfani F, Vizzielli G, Naldini A, Scambia G.
    Gynecol Oncol; 2009 Jun 15; 113(3):335-40. PubMed ID: 19345401
    [Abstract] [Full Text] [Related]

  • 14. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM, Moore KN, Myers TK, Lanneau GS, McMeekin DS, Walker JL, Gold MA.
    Gynecol Oncol; 2009 Feb 15; 112(2):337-41. PubMed ID: 19041126
    [Abstract] [Full Text] [Related]

  • 15. Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot.
    van der Vange N, van Goethem AR, Zoetmulder FA, Kaag MM, van de Vaart PJ, ten Bokkel Huinink WW, Beijnen JH.
    Eur J Surg Oncol; 2000 Nov 15; 26(7):663-8. PubMed ID: 11078613
    [Abstract] [Full Text] [Related]

  • 16. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H.
    Ann Surg Oncol; 2008 Sep 15; 15(9):2426-32. PubMed ID: 18521686
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Five-year survival after second-line cisplatin-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Recio FO, Piver MS, Hempling RE, Driscoll DL.
    Gynecol Oncol; 1998 Mar 15; 68(3):267-73. PubMed ID: 9570979
    [Abstract] [Full Text] [Related]

  • 19. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M.
    Ann Surg Oncol; 2007 Oct 15; 14(10):2790-7. PubMed ID: 17661150
    [Abstract] [Full Text] [Related]

  • 20. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I, Saip P, Eralp Y, Selam M, Topuz S, Ozluk Y, Aydin Y, Topuz E.
    Gynecol Oncol; 2008 Jan 15; 108(1):136-40. PubMed ID: 17936342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.